The findings in this study do not exclude that NOVA2 could also mediate effects in the endothelium through a mechanism independent of FLT1 splicing which could further reduce endothelial dysfunction and ameliorate maternal syndrome. Here, FLT1 is linked to endothelial dysfunction.